Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I hope you realize that this is a good move on the company’s part. Interest rates are starting to move down. The fed cut 50 BP on Wednesday and have signaled many more to come. That makes these financial buys very smart and will start to be profitable very soon in my opinion!
This week will be another interesting week for NOW. Wondering if and when Bill will ask the board to split the stock. It never has split so far. Time will tell.
Yes and what the PR says b4 markets open Monday…
I know right, but nobody is talking about it except Cramer🤔🤔🤔
You’re welcome. In my opinion, this stock is setting up to be a high flyer. The debt is being addressed and being paid off. All good things take time! Go SOFI
SOFI CEO Anthony Noto to appear on CNBC within the 1/2 hour. Go SOFI
Earnings out. 3rd consecutive profitable qtr. Go SOFI!
https://www.businesswire.com/news/home/20240730317295/en/
Very good news, let’s go higher!!
Yes, go ahead and short it because that has worked so well for so long🙂😂😂🤣🤣. We love it when shorty has to cover.
Agree, sure hurts to see other stocks go up so much quicker… we will be rewarded in the end. Patience. Maybe some BIG surprises on 7/30 earnings report!
Yes, you and I have the exact same thoughts. I did already pocket 50k on this stock last year when it went from below 5 to above 11, but of course I started buying again when it dropped below 7. I am hoping for another double and for it to keep going as the rates start dropping by the fed
That was the intent of the last public offering. According to Anthony Noto, CEO, they did the offering to reduce debt. Looks like it is working so far.
Service Now is such a great company run by a very smart CEO Bill McDermott. I often wonder why more people do not see this or post about it. This forum has been dead since 2021. Now is the time. We are at a precipice and this stock is going to the moon in my humble opinion and I for one will continue to buy on dips and hold.
I am buying…
Would be nice, someone needs to rescue this thing. No news and dropping like a rock…
Yes, I saw the same ad last week before the market opened on Thursday. Interesting…
The company expects less earnings during the 2nd qtr so stock is getting punished again. This is such a manipulated stock. Must continue to wait. That is ok, I am in for the long haul. Overall direction is up no matter what the shorts try to do.
Yes, very good. Second straight profitable quarter. Blow the lid off this thing!
If it doesn’t hit $3 this year, will you go away for good?
Hit and in the rear view mirror…I think Monday is going to be awesome…Noto is scheduled to talk on CNBC Monday after earnings call.
I totaagree with you
Does anyone have information about the stock spinoff that occurred last year with this company? I have 600 shares of the spinoff security with 0 value and has remained that way since the spinoff. Thanks…
4/29/24
Noto did a great job of explaining the latest offering last night. They pay back current debt which is financed at 12.75% by May 1 and they restructured the debt down to 1.75% if not interest rate would jump to over 14% . Can’t wait to see this stock explode at next 2 earnings reports when these decisions bear fruit …
Noto to be interviewed on Mad Money tonight 3/20/24. Cramer to ask him about the latest offering…stay tuned
Wow, what a turn around…yesterday you said the exact opposite…
Look at her history she sells at many points along the way. It is always smart to trim positions periodically especially those at stratospheric levels such as NVDA is.
Count me in that group too. Continue to take a little off the top as it goes into the stratosphere…Go NVDA!!!
I think they are just too stupid to figure it out. You can dilute with less shares at a higher price…come on man!!
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock
February 09, 2024 08:30 AM Eastern Standard Time
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced the pricing of an offering of 3,875,000 shares of its common stock at an offering price of $2.00 per share, for gross proceeds of $7.75 million, before deducting underwriting discounts and offering expenses. All of the shares of common stock are being offered by the Company. The offering is expected to close on February 13, 2024, subject to satisfaction of customary closing conditions.
The Company intends to use the net proceeds from this offering to fund the continued development of Multikine*, for general corporate purposes, and working capital.
ThinkEquity is acting as sole book-running manager for the offering.
The securities will be offered and sold pursuant to a shelf registration statement on Form S-3 (File No. 333-265995), including a base prospectus, filed with the U.S. Securities and Exchange Commission (the “SEC”) on July 1, 2022 and declared effective on July 15, 2022. The offering will be made only by means of a written prospectus. A prospectus supplement and accompanying prospectus describing the terms of the offering has been or will be filed with the SEC on its website at www.sec.gov. Copies of the prospectus supplement, when available, and the accompanying prospectus relating to the offering may also be obtained from the offices of ThinkEquity, 17 State Street, 41st Floor, New York, New York 10004. Before investing in this offering, interested parties should read in their entirety the prospectus supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
So true, but as we know this is happening, it does give us a great opportunity to buy more…
NEWS OUT- causing stock to be “in-play” and going up
https://feeds.issuerdirect.com/news-release.html?newsid=7643495042413725
European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine®
CEL-SCI has cleared a significant hurdle that mandates cancer drugs in Europe comply with strict requirements for pediatric usage and clinical evidence
CEL-SCI Corporation (NYSE American: CVM) today announced that the European Medicines Agency (EMA) Paediatric Committee granted CEL-SCI a product-specific waiver of strict requirements for commercialization of cancer drugs in the European Union (EU). According to the opinion letter:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240131910101/en/
Shorty should continue to be squeezed for the next couple days…
Anthony Noto going to be interviewed on CNBC up next…
Don’t poke him/her let sleeping dogs lie it was so nice for the time when they stopped posting…go SOFI. Cramer will have Anthony on soon and higher we go…
Agree, it will take time as we need upgrades that will be coming…we went over 10 on the last bunch of upgrades look for more upgrades and higher price…just my two cents worth.
Yes it is…Anthony Noto right on with his predictions and now it is up 20% pre market…WOW!!
Here is another story from Market Watch…
SoFi’s stock rockets as earnings blow past expectations on surging loan volumes
Published: Jan. 29, 2024 at 7:16 a.m. ET
By Emily Bary
Company delivers GAAP profit for fourth quarter
SoFi Technologies Inc. shares were surging in premarket trading Monday after the financial-technology company rode surging lending volumes to better-than-expected profitability for the latest quarter.
The company posted fourth-quarter net income of $48 million, or 2 cents a share, whereas it generated a loss of $40 million, or 5 cents a share, in the year-prior period. Analysts tracked by FactSet expected the company to break even on a per-share basis.
SoFi SOFI also reported adjusted earnings before interest, taxes, depreciation and amortization (Ebitda) of $181 million, up from $70 million in the year-before period. The FactSet consenus was for $142 million.
Total net revenue came in at $615 million, up 35% from a year prior. Analysts had been looking for $575 million.
The company expects to see $550 million to $560 million of adjusted net revenue in the first quarter, along with $110 million to $120 million of adjusted Ebitda. Analysts were modeling $578 million in adjusted net revenue and $125 million in adjusted EPS.
Origination volumes for personal loans were up 31% in the fourth quarter, while such volumes for student loans and home loans were up 95% and 193%, respectively.
The stock was up 11% in premarket action.
Management anticipates that the company will continue to be profitable on a GAAP basis into the first quarter, calling for $10 million to $20 million in GAAP net income, whereas the FactSet consensus was for $8 million.
For the full year, the company expects GAAP earnings per share of 7 cents to 8 cents, while analysts had been modeling 5 cents.